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◻ An alternative thin-layer chromatography (TLC) method for the determination of haloperi-
dol in pharmaceutical formulation against the method proposed by European Pharmacopeia (7.0) 
has been compared and described. The proposed method uses a mobile phase composed of acetoni-
trile/water, 60:40, with the addition of 1.5% (v/v) 1-ethyl-3-methylimidazolium tetrafluoroborate 
ionic liquid. The ionic liquid modifiers of a mobile phase have been shown to be suitable suppres-
sor of silanol ionization in the TLC of basic drugs. Besides the silanol-suppressing potency of the 
1-ethyl-3-methylimidazolium tetrafluoroborate, the lack of interaction and interference with UV 
densitometric detection was observed. These properties open a new possibilities in the application 
of alky-imidazolium-based ionic liquids in chromatographic techniques.
Keywords haloperidol, ionic liquids, mobile phase additives, solanol deactivation, 
thin-layer chromatography
INTRODUCTION
The thin-layer chromatography (TLC) of basic drugs is often  unfeasible 
because of the effect of free silanols on their chromatographic retention.[1–3] 
The undesirable effect is probably due to the ionic interactions of the 
positively charged analytes with the free silanol groups on the surface of 
silica or alkyl-bonded silica stationary phases. The ion-exchange interac-
tions cause a strong retention of basic analytes resulting in poor peak or 
spots shape and tailing. Hence, the numerous mobile-phase modifiers 
have been tested to suppress undesirable silanol effect in liquid chroma-
tography, e.g., different buffer salts, ammonia, and various amines such as 
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triethylamine (TEA), diethylamine (DEA), dimethyloctylamine (DMOA), 
or tetrabutylamine (TBA) and other primary, secondary, tertiary, and qua-
ternary amine additives.[4] Nahum and Horvath recommended them as 
additives to the eluent in liquid chromatography that can be successfully 
used in reversed phase chromatography to suppress the deleterious effect 
of free silanolic groups in stationary phase.[5] The modifiers are very pop-
ular and are often recommended by pharmacopoeias for qualitative and 
quantitative analysis of some drugs with the use of TLC method or are 
used to improve any chromatographic process of basic compounds.[6,7]
In the last decade, ionic liquids have opened a new possibility to 
improve chromatographic systems, also TLC. The role of the ionic liq-
uids is the interaction with silanol sites to reduce its deleterious effect on 
basic compounds. Due to their unique and “flexible” physical and chemi-
cal properties, ionic liquids are often called as “green chemistry” solvents 
and presently have potential application in pharmaceutical and chemical 
industry.[8] A numerous reports described recent efforts in the applica-
tion of the “green solvents” in almost all areas of analytical chemistry.[9–13] 
Ionic liquids are organic salts with low melting points that have also a 
great opportunity for a new application as solvents in chromatographic 
techniques.[14–16] The most commonly used ionic liquids in liquid chroma-
tography are salts composed of alkylammonium and imidazolium cations 
which are soluble in common chromatographic solvents.[17,18] Also the ILs 
based on the BF4, Cl, and MeSO4 anions are water-stable compounds, 
which dissolve in commonly used chromatographic mobile phases.
In most performed studies, ionic liquids have been proposed as silanol 
suppressing add itives to mobile phase.[19,20] The advantage of these suppress-
ing modifiers of mobile phase in TLC and high-performance liquid chro-
matography (HPLC) is that their addition of 0.5–2.5% v/v to mobile phase 
decreased the retention of basic analytes more markedly than other alky-
lamines.[21–25] The desirable effect of new additives probably based on the 
dual nature of ionic liquids. Both parts of the ionic salts, cation and anion, can 
affect the chromatographic retention.[26] It was demonstrated that both cati-
ons and anions of ILs could be adsorbed on hydrophobic stationary phase. 
Our previous studies showed the significant influence of 1-alkyl-3-methyl-
imidazolium cation on the silanol suppressing properties of ILs [19]. The 
1-alkyl-3-methylimidazolium tetrafluoroborate IL had a better silanol block-
ing activity on different silica-based TLC plates than ammonia and ternary 
amines (TEA, DMOA) and was successfully used for quantification of basic 
drugs and optimization of separation of peptides with TLC systems.[19,27]
The main aim of the study is the comparison of a suggested  pharmacopeial 
TLC method (European Pharmacopeia 7.0) for determination of haloperi-
dol with the chromatographic system composed of previously selected ionic 














































1526 D. Mieszkowski et al.
of haloperidol in oral drops that causes an analytical problem during the 
chromatographic process on silica-based stationary phases.
EXPERIMENTAL
Chemicals
The Haloperidol Reference Standard Was Obtained 
from POCh (Gliwice, Poland)
Both ionic liquids used in the study, 1-ethyl-3-methylimidazolium tetra-
fluoroborate ([emim][BF4]) and 1-hexyl-3-methylimidazolium tetrafluorobo-
rate ([hmim][BF4]), were purchased from Fluka Chemika (Buchs, Switzerland) 
(Figure 1). Acetonitrile, tetrahydrofuran, methanol, water, and sodium chlo-
ride with high analytical grade were from POCh (Gliwice, Poland).
The Pharmaceutical Formulation
Haloperidol Unia (oral drops containing 2 mg of haloperidol in 1 mL 
solution) was from pharmaceutical company, Zakłady Farmaceutyczne 
UNIA Spółdzielnia Pracy (Warszawa, Poland).
Apparatus
The HPTLC system was comprised of a microsyringe from Innovative 
Labor Systeme GmBH (Stützerbach, Germany), HPTLC applicator AS 30 
made by Desaga (Wiesloch, Germany), and HPTLC CD 60 densitometer 
(Desaga, Wiesloch, Germany) assisted by a computer with a ProQuant soft-
ware (Desaga, Wiesloch, Germany). Visualization of the chromatographic 
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 separation was carried out by CabUV-VIS (Desaga, Wiesloch, Germany) 
and documented using a Canon Power Shot G5 digital camera with 
ProViDoc 3.0 (Desaga, Wiesloch, Germany). The chromatographic pro-
cess was performed using horizontal developing chambers from Modin 
(Lublin, Poland) and HPTLC RP-18 glass plates (10 cm × 20 cm) precoated 
with silica gel 60 F254 (Fluka, Germany).
Methods
Quantitative analysis of haloperidol by HPTLC was conducted using 
densitometer and applicator. A 1 µL of stock solution in appropriate con-
centration and test solutions of haloperidol were applied on the glass plates 
RP-18 of 10 cm × 20 cm in size, 10 mm from the bottom edge. Further, the 
HPTLC plates were placed in chromatographic chamber, previously satu-
rated with the mobile phase suggested by European Pharmacopeia (7.0) 
for TLC haloperidol identity testing (tetrahydrofuran/methanol/sodium 
chloride solution (58 g/L), 10:45:45 v/v/v). Afterwards, developed and 
dried at room temperature, plates were subjected to densitometric analy-
sis at a wavelength of 245 nm. The length of chromatogram run was 8 cm.
Identical procedure and analysis were also performed for other plates, 
placed in separate chambers saturated with vapor of chromatographic 
mobile phases consisting of acetonitrile/water/[emim][BF4] (60:40:1.5 
v/v/v) and acetonitrile/water/[hmim][BF4] (60:40:1.5 v/v/v).
Canon Power Shot G5 digital system in combination with ProViDoc 
3.0 (Desaga, Wiesloch, Germany) was used for visualization, imaging, and 
archiving developed high-performance thin-layer plates.
Standard Solution and Analytical Procedure 
for the Assay of Haloperidol
Standard solution was prepared by dissolving 5.0 mg of haloperidol 
in 5 mL methanol to obtain the concentration of 1 mg/mL. The calibra-
tion curves were plotted from seven dilutions (0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 
and 0.9 mg/mL of haloperidol) of the standard solution of haloperidol. 
Working solutions of the studied compound (0.5 mg/mL) were prepared 
by dilution of haloperidol drops with methanol or water with an analytical 
HPLC grade. For the calibration curves, 1 µL of all standards and sam-
ples were applied to the HPTLC RP-18 plates by means of the HPTLC 
Applicator AS 30 equipped with a 25-µL microsyringe. Thirteen bands 
per plate were applied 10 mm from the bottom edge, 13 mm apart. The 
rate of application was constant and was set at 14 s/µL. 250 µL of 
haloperidol oral drops (2 mg/mL) were diluted with 750 µL of methanol 
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RESULTS AND DISCUSSION
Preliminary study with the use of [emim][BF4] as a TLC mobile phase 
additive was performed in order to compare the effect of imidazolium-
based ionic liquid on the chromatographic retention of haloperidol. 
The TLC plates were developed with acetonitrile/water (60:40 v/v) elu-
ent, either neat or with 0.5, 1.5, or 2.0% (v/v) of [emim][BF4]. The strong 
retention of the tested analyte was observed in the mobile phase without 
the ionic liquid (Table 1). The “tailing” spot (Rf = 0.05) of haloperidol on a 
octadecyl-silica plate confirms the undesirable interactions of base analyte 
with free silanols on the surface of stationary phase. However, when the 
small amount of IL was added (0.50% v/v), the retention of the haloperi-
dol decreased but the shape of the spot was still irregular. The addition 
of threefold concentration of [emim][BF4] to the mobile phase caused a 
further decrease in chromatographic retention of the drug. The excess 
of studied IL over 1.5% (v/v) did not improve the chromatographic pro-
cess (Table 1). Next, based on the observation the 1.5% (v/v) of [emim]
[BF4] and [hmim][BF4] as a mobile phase, additives were investigated and 
compared with chromatographic method recommended by the European 
Pharmacopoeia (7.0).
The comparative analysis with a mobile phase suggested by European 
Pharmacopeia (7.0) involves the TLC determination of haloperidol with 
the use of tetrahydrofuran/methanol/sodium chloride solution (58 g/L) 
(10:45:45 v/v/v) as an eluent. Seven various concentrations of standard 
stock solution of haloperidol were spotted on octadecyl-silica plates (0.3, 
0.4, 0.5, 0.6, 0.7, 0.8, and 0.9 mg/mL) and developed using three differ-
ent mobile phase: (1) Pharmacopeial, (2) 1.5% (v/v) of [emim][BF4], and 
(3) 1.5% (v/v) of [hmim][BF4] (Figure 2). Parallel, the three spots with 
methanol and aqueous solution of haloperidol oral drops were developed 
on the same TLC plate. Based on the Rf values and shape of spots, one 
can conclude that all studied eluents were acceptable for TLC separation 
and determination of haloperidol. Also, the comparison of Rf values with 
acceptable standard deviation (SD) can be taken as evidence of the use-
ful of all three chromatographic systems for the quantitative analysis of 
 haloperidol (Table 2).
TABLE 1 Rf Values of Haloperidol Using Different Concentrations of [emim][BF4] as Modifier of 
Mobile Phase (Acetonitrile/Water, 60:40 v/v)
Haloperidol
Concentration of [emim][BF4] in 
(acetonitrile/water, 60:40 v/v)
0% (v/v) 0.5% (v/v) 1.5% (v/v) 2% (v/v)
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Next, the three studied mobile phases were compared as a  potential 
thin-layer chromatographic system for the quantification of haloperidol in 
pharmaceutical formulations. For the quantitative analysis, the HPTLC-UV 
densitometric method was used. The optimal conditions of UV densito-
metric scanning were determined in the range of 190 to 400 nm and the 
analytical wavelength was adjusted at λ = 245 nm. The representative den-
sitograms are presented in Figure 3. The use of  tetrahydrofuran/metha-
nol/sodium chloride as a mobile phase and the 1.5% (v/v) of [emim][BF4] 
additive to acetonitrile/water did not influence the strength of the signal. 
The significant decrease in  signal intensity was observed for densitogram 
from the chromatographic system with acetonitrile/water, 60:40 (v/v), 
mobile phase and with 1.5% (v/v) of [hmim][BF4] as an additive. That can 
FIGURE 2 Representative HPTLC plates of developed HPTLC plate in different chromatographic 
system. Tracks 1–7, the increasing concentrations of haloperidol (0.3–0.9 mg/mL); Tracks 8–10, 
0.5 mg/mL (aqueous solutions); Tracks 11–13, 0.5 mg/mL (methanol solutions).
Mobile phase: I—tetrahydrofuran/methanol/sodium chloride (58 g/L), 10:45:45 (v/v/v).
II—acetontrile/water, 60:40 (v/v), with 1.5 % (v/v) of [emim][BF4].
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TABLE 2 Comparison of Studied Chromatographic HPTLC Systems with  Regard to the 
Retardation Coefficient (Rf) and Standard Deviation for  Haloperidol (n = 3)
Concentration of 
haloperidol (mg/mL)
Mobile phase 1 Mobile phase 2 Mobile phase 3
Rf Rf Rf
0.30 0.177 ± 0.063 0.513 ± 0.035 0.400 ± 0.127
0.40 0.177 ± 0.063 0.503 ± 0.050 0.407 ± 0.119
0.50 0.180 ± 0.061 0.510 ± 0.041 0.470 ± 0.061
0.60 0.180 ± 0.061 0.513 ± 0.040 0.497 ± 0.061
0.70 0.183 ± 0.058 0.520 ± 0.046 0.497 ± 0.055
0.80 0.183 ± 0.058 0.517 ± 0.042 0.463 ± 0.084
0.90 0.183 ± 0.058 0.520 ± 0.046 0.460 ± 0.101
Mobile phase: 1—tetrahydrofuran/methanol/sodium chloride (58 g/L), 10:45:45 (v/v/v).
2—acetonitrile/water, 60:40 (v/v), with 1.5% (v/v) of [emim][BF4].
3—acetonitrile/water, 60:40 (v/v), with 1.5% (v/v) of [hmim][BF4].
be due to the hexyl chain in imidazolium ring, which probably hinder the 
densitometric detection.
The calculated standard curves were evaluated by linear regression 
(y = ax + b) using the least squares approach (Table 3). The calibration curve 
equations were estimated by linear regression analysis (peak area versus 
drug quantity per spot). Linear correlation between the peak area and the 
FIGURE 3 Representative densitograms obtained by scanning HPTLC plates with the wavelength 
at 245 nm in different chromatographic systems. Tracks 1–7, the increasing concentrations of 
 haloperidol (0.3–0.9 mg/mL); Tracks 8–10, 0.5 mg/mL (aqueous solutions); Tracks 11–13, 0.5 mg/mL 
(methanol solutions).
Mobile phase: I–tetrahydrofuran/methanol/sodium chloride (58 g/L) 10:45:45 (v/v/v).
II–acetonitrile/water 60:40 (v/v) with 1.5 % (v/v) of [emim][BF4].



































































































































































































































































































































































































































































































































1532 D. Mieszkowski et al.
concentration of haloperidol in the range of 0.3 to 0.9 mg/mL was found 
with a highest correlation coefficient of 0.995 for tetrahydrofuran/metha-
nol/sodium chloride mobile phase and the lowest (0.907) for the mobile 
phase composed of 1.5% (v/v) of [hmim][BF4]. The efficiency of the tet-
rahydrofuran/methanol/sodium chloride and [emim][BF4] based mobile 
phase is confirmed by the acceptable recovery in the range of 99.36% to 
106.50%. However, the value of recovery for the methanol dilution of halo-
peridol oral drops is significantly higher than the aqueous dilution. The 
differences in assays are probably due to the methanol––water contraction 
phenomena occurring in resulted solutions. As a result of intermolecular 
interactions between the components of the mixture (methanol as solvent 
and purified water from the droplets), agglomerate occurs, resulting in a 
change of volume and thus the concentration of obtained methanol solu-
tion is slightly higher than that in the case of water solution.
The unsatisfactory recovery (82.96–85.52) for [hmim][BF4] used as an 
mobile phase additive was observed, regardless of chemical solution. The 
unacceptable value is probably related with low value of correlation coef-
ficient (0.907) and low precision with mean of relative standard deviation. 
One of the explanation of the phenomena is that the efficient suppres-
sion of the free silanols interaction increased with the length of the alkyl 
chain at position C-1 of the imidazolium ring [21]. Thus the hexyl chain 
attached to the C1 position can stabilize the silanol–imidazolium complex 
by hydrophobic interaction between the alkyl chain of the ionic liquid and 
the octadecyl-bonded silica phase. Such stable imidazolium–silanol com-
plex and long chain can distort the chromatographic process and densi-
tomertic measurements.
CONCLUSION
The addition of 1.5% (v/v) of ionic liquids as mobile phase modifi-
ers appears to give an equivalent separation of haloperidol compared to 
the mobile phase suggested by European Pharmacopeia 7.0. The results 
with [emim][BF4] as the mobile phase additive give similar separation and 
quantitative results with no peak tailing, confirming the positive effect of 
ionic liquids on the chromatographic behavior of basic drugs. However, 
the longer chain length ionic liquid [hmim][BF4] when added as a 1.5% 
modifier, gives a satisfactory separation but lacks the precision for it to be 
recommended as a suitable additive for haloperidol mobile phase.
The application of ionic liquids as additives of mobile phase allows to 
solve problems of silanol interaction in liquid chromatography of basic 
compounds. The results demonstrate that the alkyl-imidazolium class ionic 
liquids with short alkyl-chain length are particularly suitable modifier of 
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can be an alternative mobile phase in determination of haloperidol in 
comparison with tetrahydrofuran/methanol mixture. Undoubtedly, the 
individual conditions should be optimized to respective determination of 
compound.
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